BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38663779)

  • 21. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
    Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
    Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
    Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
    Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
    Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
    Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats.
    Du H; Li C; Wang Z; He Y; Wang Y; Zhou H; Wan H; Yang J
    J Ethnopharmacol; 2021 Jun; 274():114058. PubMed ID: 33766756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.
    Ding L; Yang Y; Qu Y; Yang T; Wang K; Liu W; Xia W
    Mol Med Rep; 2015 Jun; 11(6):4431-7. PubMed ID: 25634785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism.
    Deng R; Yang D; Radke A; Yang J; Yan B
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1153-62. PubMed ID: 17135343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids.
    Huang S; Wu Q; Liu H; Ling H; He Y; Wang C; Wang Z; Lu Y; Lu Y
    J Ethnopharmacol; 2019 Sep; 241():111976. PubMed ID: 31132462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.
    Cui J; Huang L; Zhao A; Lew JL; Yu J; Sahoo S; Meinke PT; Royo I; Pelaez F; Wright SD
    J Biol Chem; 2003 Mar; 278(12):10214-20. PubMed ID: 12525500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice.
    Fuchs CD; Krivanec S; Steinacher D; Mlitz V; Wahlström A; Stahlman M; Claudel T; Scharnagl H; Stojakovic T; Marschall HU; Trauner M
    Liver Int; 2020 Jun; 40(6):1366-1377. PubMed ID: 32141703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
    Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
    J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual bile acids have differential effects on bile acid signaling in mice.
    Song P; Rockwell CE; Cui JY; Klaassen CD
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
    Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
    J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geniposide reduces cholesterol accumulation and increases its excretion by regulating the FXR-mediated liver-gut crosstalk of bile acids.
    Liu J; Li Y; Sun C; Liu S; Yan Y; Pan H; Fan M; Xue L; Nie C; Zhang H; Qian H; Ying H; Wang L
    Pharmacol Res; 2020 Feb; 152():104631. PubMed ID: 31911244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression.
    Song X; Kaimal R; Yan B; Deng R
    J Lipid Res; 2008 May; 49(5):973-84. PubMed ID: 18270374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polygonum multiflorum Thunb suppress bile acid synthesis by activating Fxr-Fgf15 signaling in the intestine.
    Wei J; Chen J; Fu L; Han L; Gao X; Sarhene M; Hu L; Zhang Y; Fan G
    J Ethnopharmacol; 2019 May; 235():472-480. PubMed ID: 30528660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
    Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
    J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
    Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
    J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.
    Yang F; Wang Y; Li G; Xue J; Chen ZL; Jin F; Luo L; Zhou X; Ma Q; Cai X; Li HR; Zhao L
    Br J Pharmacol; 2018 Mar; 175(5):810-829. PubMed ID: 29235094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.